Research confirms safety and efficacy of RemiFemin for menopausa...( was conducted at four gynecological cli...),Health

was conducted at four gynecological clinics in Poland in accordance with the Good Clinical Practice Guideline. The study included 150 peri- and postmenopausal women between the ages of 42 and 60 with moderate to severe menopause symptoms. The study was conducted over a 12-week treatment period, with the majority of women enrolling in a continuation study to 24 weeks. A number of scales were used to measure menopause symptoms, including the Kupperman Menopause Index and the Self-Rating Depression Scale.

Background

A third of American women - more than 35 million - are now perimenopausal, and between 50-80% of them will experience acute symptoms, such as hot flashes, mood swings and sleeplessness. As many as 85% of women who experience hot flashes have them for more than one year, and 25 to 50% have them for up to five years. As such, many women seek medical attention to alleviate their menopause symptoms.

Hormone replacement therapy (HRT) is a commonly prescribed treatment for relief of distressing menopausal symptoms. While HRT has been used for years to relieve menopause symptoms and also protect bone health, there are a number of possible side effects associated with HRT that raise questions regarding the safety of HRT use in all women. Because HRT is contraindicated in certain populations, particularly in patients with estrogen sensitive cancers of the breast and uterus, natural, herbal treatments are gaining popularity for the relief of short-term symptoms of menopause.

While many herbal remedies have not been widely studied, there is an abundance of rigorous scientific data that support the safety and efficacy of black cohosh (Cimicifuga racemosa) extracts - sold under the name RemiFemin Menopause in the United States - for the treatment of menopause symptoms. The German Commission E, a regulatory body established by the German Federal Health Authorities similar to the FDA, has approved black cohosh as a t
'"/>

Contact: Sarah Oetgen
soetgen@senseihealth.com
202-337-4582
Sensei Health
25-Mar-2002

Page: 1 2 3
Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award